A case of a highly sensitised haemodialysis patient who developed severe vascular rejection in her third renal allograft is presented. This severe rejection episode responded to mycophenolate mofetil (MMF) and high dose steroids.
RowePA, FanKS, GardinerDS, MacphersonSG, RodgerRS Bradley JA, JunorBR, BriggsJD. Long-term outcome of the use of OKT3 to treat steroid-resistant acute renal allograft rejection. Transpl Int.1994; 7: 278–83.
2.
Van der WoudeFJ. Mycophenolate mofetil ( RS-61443): Nothing new under the sun or an important break-through in the field of transplantation. Nephrol Dial Transplant1995; 10: 1112–1114.
The Mycophenolate Mofetil Renal Refractory Rejection Study Group. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. Transplantation1996; 61: 722–29.
